Skip to content
Open access · CC-BY via OpenAlex

Heterocyclic compounds as a magic bullet for diabetes mellitus: a review

Umme Farwa, Muhammad Asam Raza

RSC Advances · 2022 · ▲ 46 citations

Abstract

. Molecular docking of the studied compounds as antidiabetic molecules was performed with the help of Auto Dock and molecular operating environment (MOE) software. Amino acid residues Asp349, Arg312, Arg439, Asn241, Val303, Glu304, Phe158, His103, Lys422 and Thr207 that are present on the active sites of diabetic related enzymes showed interactions with ligand molecules. In this review data were organized for the synthesis of heterocyclic compounds through various routes along with their antidiabetic potential, and further studies such as pharmacokinetic and toxicology studies should be executed before going for clinical trials.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1039/d2ra02697j
Canonical
link ↗
Fetched
2026-06-29 MST

Cite this

APA
Farwa, U., &amp; Raza, M.A. (2022). Heterocyclic compounds as a magic bullet for diabetes mellitus: a review. <em>RSC Advances</em>. https://doi.org/10.1039/d2ra02697j
Vancouver
Farwa U, Raza MA. Heterocyclic compounds as a magic bullet for diabetes mellitus: a review. RSC Advances. 2022. doi:10.1039/d2ra02697j.
BibTeX
@article{umme2022Hetero, title = {Heterocyclic compounds as a magic bullet for diabetes mellitus: a review}, author = {Umme Farwa and Muhammad Asam Raza}, journal = {RSC Advances}, year = {2022}, doi = {10.1039/d2ra02697j}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings